Published on 19 February 2010
EDCTP is holding a meeting with key representatives from European National Development agencies or their equivalent to explore pragmatic and workable strategies for collaborating together most effectively in line with the Declarations of Paris (2005) and Bamako (2007). The meeting will take place on 9 June 2010 at the University Foundation in Brussels, Belgium. The meeting will discuss how to better coordinate clinical research and health development agendas in Africa in order to facilitate effective delivery of interventions.
Background
EDCTP aims to accelerate the development of new or improved intervention tools against the main three diseases of poverty namely HIV/AIDS, tuberculosis and malaria. The current mandate of EDCTP is to support conduct of clinical trials for drugs, vaccines, microbicides and diagnostics. This incorporates capacity building which includes fostering an enabling environment to ensure that this is done using best practice including good clinical practice and good clinical laboratory practice, following internationally accepted ethical and regulatory standards. EDCTP realises these aims by coordinating European member states to work in partnership with African counterparts and third parties. The third parties include all like-minded organisation, pharmaceutical industry, Public-Private Product Development Partnerships (PDPs) and all other stakeholders working on these diseases. EDCTP intends to expand the current focus to include all clinical trial phases (I-IV) as well as research into health services particularly exploring how best to deliver new products to the target populations. EDCTP therefore, recognises the significant role of Development Agencies as the natural partners for strengthening of health systems and capacity development.
The purpose of the meeting is to inform European Development agencies of the relevance of the EDCTP programme to their health development agenda in Africa; to better understand existing gaps between current research and development agendas and obstacles to better collaboration; to explore how integrated capacity development and networking can be achieved; and to explore how the outputs from clinical trials can be utilised in better coordinated and effective ways, promoting translation of results into policies.
« Return to news overview
